FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094931 [Registered on: 16/09/2025] Trial Registered Prospectively
Last Modified On: 08/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Effect of fibrin glue on surgical site discharge in patients undergoing total thyroidectomy. 
Scientific Title of Study   Comparison of postoperative wound drainage with and without use of fibrin sealant in patients undergoing total thyroidectomy- A Randomized Controlled Study. 
Trial Acronym  NIL  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ashish Kumar 
Designation  Postgraduate resident  
Affiliation  Maulana Azad Medical College Dr  
Address  Office of Department of Surgery, 2nd floor, BL Taneja Block, Maulana Azad Medical College, New Delhi

New Delhi
DELHI
110002
India 
Phone  9354673979  
Fax    
Email  ashishpanghal2001@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chandra Bhushan Singh 
Designation  Director Professor and Head of Department  
Affiliation  Maulana Azad Medical College and Associated Hospitals  
Address  Office of Head of Department,Department of Surgery, 2nd floor, BL Taneja Block, Maulana Azad Medical College, New Delhi

New Delhi
DELHI
110002
India 
Phone  9717212602  
Fax    
Email  drchandrabhushansingh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Chandra Bhushan Singh 
Designation  Director Professor and Head of Department  
Affiliation  Maulana Azad Medical College and Associated Hospitals  
Address  Office of Head of Department,Department of Surgery, 2nd floor, BL Taneja Block, Maulana Azad Medical College, New Delhi

New Delhi
DELHI
110002
India 
Phone  9717212602  
Fax    
Email  drchandrabhushansingh@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College and Associated Lok Nayak Hospital, New Delhi. 
 
Primary Sponsor  
Name  Maulana Azad Medical College and Associated Lok Nayak Hospital  
Address  Maulana Azad Medical College Campus,2, Bahadur Shah Zafar Marg, Near Delhi Gate, Balmiki Basti,New Delhi, Delhi-110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashish Kumar   Lok Nayak Hospital  OT-1, Main OT Block, Department of General surgery, LNJP Colony
New Delhi
DELHI 
9354673979

ashishpanghal2001@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Maulana Azad Medical College and Associated Hospitals   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E05||Thyrotoxicosis [hyperthyroidism], (2) ICD-10 Condition: E06||Thyroiditis, (3) ICD-10 Condition: E07||Other disorders of thyroid, (4) ICD-10 Condition: C73||Malignant neoplasm of thyroid gland, (5) ICD-10 Condition: D34||Benign neoplasm of thyroid gland, (6) ICD-10 Condition: E079||Disorder of thyroid, unspecified, (7) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Fibrin sealant instillation  After specimen retrieval and achieving hemostasis, 4 ml of fibrin sealant will be put using spray method under both flaps with placement of 10 Fr mini romovac drain before skin closure in total thyroidetomy patients. 
Comparator Agent  No fibrin sealant   After specimen retrieval and achieving hemostasis, flaps will be repositioned and skin closed with placement of 10 Fr Miniromovac drain in total thyroidectomy. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients undergoing total thyroidectomy. 
 
ExclusionCriteria 
Details  Revision surgery.
Patients undergoing central and lateral neck dissection.
Pregnancy and lactation.
Coagulation disorders.
History of previous irradiation.
Extrathyroidal extension.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Post operative drain output   At 24 hours post operatively.
Total output till drain removal. 
 
Secondary Outcome  
Outcome  TimePoints 
Duration of drain requirement.
 
POD0 to till drain removal  
Incidence of hematoma formation.   42 days post operatively  
Incidence of surgical site infection.  42 days post operatively  
Duration of Hospital Stay.  POD0 to discharge  
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers who provide a methodologically sound proposal.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [ashishpanghal2001@gmail.com].

  6. For how long will this data be available start date provided 01-09-2026 and end date provided 01-09-2031?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary   This study is being done to evaluate the role of fibrin sealant in decreasing postoperative complications like seroma and hematoma formation in patients undergoing total thyroidectomy which in turn can lead to decreasing drain requirement and hospital stay aftr thyroid surgery. Multiple earlier studies have shown variable results and the use o fibrin sealant in thyroid surgeries is still under scrutiny. In this study, 4 ml of fibrin sealant will be sprayed in surgical bed and skin closed using standard technique. post operative drain output will be compared in the study and control group and total duration of drain requirement will be assessed. this study can provide a useful role of fibrin sealant in decreasing postoperative morbidity and hospital stay of thyroid patients. 
Close